Menu
GeneBe

IFI27

interferon alpha inducible protein 27

Basic information

Region (hg38): 14:94104835-94116695

Links

ENSG00000165949NCBI:3429OMIM:600009HGNC:5397Uniprot:P40305AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the IFI27 gene.

  • Inborn genetic diseases (5 variants)
  • not provided (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the IFI27 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
4
clinvar
1
clinvar
5
nonsense
0
start loss
0
frameshift
0
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 4 1 1

Variants in IFI27

This is a list of pathogenic ClinVar variants found in the IFI27 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
14-94111740-G-T not specified Uncertain significance (Dec 18, 2023)3108123
14-94115784-T-TGGCCATGGC Benign (Dec 31, 2019)768677
14-94115843-G-A not specified Likely benign (Jun 21, 2022)2411105
14-94115895-G-C not specified Uncertain significance (Aug 22, 2023)2621006
14-94115919-T-C not specified Uncertain significance (Jul 21, 2021)2369258
14-94116473-C-G not specified Uncertain significance (Feb 17, 2022)2277587
14-94116488-T-G not specified Uncertain significance (Jan 26, 2023)2460290

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
IFI27protein_codingprotein_codingENST00000555744 411852
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.01070.635114914011149150.00000435
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.4146069.70.8610.00000390708
Missense in Polyphen710.1730.6881298
Synonymous0.006133232.00.9990.00000229280
Loss of Function0.40533.860.7781.63e-748

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000009700.00000970
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Probable adapter protein involved in different biological processes (PubMed:22427340, PubMed:27194766). Part of the signaling pathways that lead to apoptosis (PubMed:18330707, PubMed:27673746, PubMed:24970806). Involved in type-I interferon- induced apoptosis characterized by a rapid and robust release of cytochrome C from the mitochondria and activation of BAX and caspases 2, 3, 6, 8 and 9 (PubMed:18330707, PubMed:27673746). Also functions in TNFSF10-induced apoptosis (PubMed:24970806). May also have a function in the nucleus, where it may be involved in the interferon-induced negative regulation of the transcriptional activity of NR4A1, NR4A2 and NR4A3 through the enhancement of XPO1-mediated nuclear export of these nuclear receptors (PubMed:22427340). May thereby play a role in the vascular response to injury (By similarity). In the innate immune response, has an antiviral activity towards hepatitis C virus/HCV (PubMed:27194766, PubMed:27777077). May prevent the replication of the virus by recruiting both the hepatitis C virus non-structural protein 5A/NS5A and the ubiquitination machinery via SKP2, promoting the ubiquitin-mediated proteasomal degradation of NS5A (PubMed:27194766, PubMed:27777077). {ECO:0000250|UniProtKB:Q8R412, ECO:0000269|PubMed:18330707, ECO:0000269|PubMed:22427340, ECO:0000269|PubMed:24970806, ECO:0000269|PubMed:27194766, ECO:0000269|PubMed:27673746, ECO:0000269|PubMed:27777077}.;
Pathway
Cytokine Signaling in Immune system;Immune System;Interferon alpha/beta signaling;Interferon Signaling (Consensus)

Recessive Scores

pRec
0.0647

Intolerance Scores

loftool
0.621
rvis_EVS
0.37
rvis_percentile_EVS
74.95

Haploinsufficiency Scores

pHI
0.0392
hipred
N
hipred_score
0.112
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.146

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ifi27l2b
Phenotype

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;apoptotic process;viral process;proteasome-mediated ubiquitin-dependent protein catabolic process;modulation by host of viral genome replication;innate immune response;regulation of protein export from nucleus;defense response to virus;type I interferon signaling pathway;protein K48-linked ubiquitination;extrinsic apoptotic signaling pathway
Cellular component
nuclear envelope;nuclear inner membrane;mitochondrion;mitochondrial outer membrane;endoplasmic reticulum membrane;integral component of membrane;mitochondrial membrane
Molecular function
RNA polymerase II activating transcription factor binding;molecular_function;protein binding;lamin binding;identical protein binding